Publications by authors named "L O LANGER"
Objective: The present study aimed to evaluate patients' knowledge about their newly prescribed medications, contributing factors, and preferred sources of medication-related information.
Methods: A cross-sectional study using an online survey was conducted among 931 customers of a mail-order pharmacy. Medication-related knowledge was examined using a novel knowledge index (KI) assessing medication dosage, indication, time of administration, and side effects.
Background: Nursing care insurance companies in Germany have the legal mandate to develop measures to strengthen the health resources of residents of nursing homes. The present study aimed to examine a mindfulness-informed mind-body intervention (on-site and app) adapted for residents in nursing homes regarding their effect on health-related parameters.
Methods: A pilot study (DRKS00030409) was carried out with three groups in twelve nursing homes (RCT).
Article Synopsis
- - The study focuses on the relationship between mRNA translation and decay in human cells, specifically highlighting the role of the cytoplasmic exosome in degrading mRNA linked to ribosomes during quality control.
- - Researchers identified that HBS1L3 (SKI7) facilitates a direct physical coupling between EXO10 and the ribosome-bound SKI238 complex, enabling efficient mRNA handover for degradation.
- - They discovered that the decay process involves a supercomplex formed by the exosome and ribosome, allowing mRNA to be efficiently threaded from the ribosome through the helicase to the exoribonuclease, effectively coordinating the decay mechanism.
Objective: To describe and compare adverse event (AE) incidence, type, severity, and preventability in the Canadian inpatient rehabilitation setting.
Design: In this retrospective case series, AEs were identified through chart reviews from two Canadian academic tertiary post-acute care hospitals. AEs were characterized through descriptive statistics and compared using the Mantel-Haenszel and Fisher's exact tests.
Purpose: To describe the therapy approaches and clinical outcomes of an integrated care model for patients with functional movement disorder (FMD).
Materials And Methods: A retrospective chart review was conducted for all treated individuals with a primary diagnosis of FMD between January 2020 and July 2022. Patients received time-limited integrated therapy ( = 21) (i.